Your browser doesn't support javascript.
loading
The ATF4-RPS19BP1 axis modulates ribosome biogenesis to promote erythropoiesis.
Zheng, Zhaofeng; Yang, Shangda; Gou, Fanglin; Tang, Chao; Zhang, Zhaoru; Gu, Quan; Sun, Guohuan; Jiang, Penglei; Wang, Nini; Zhao, Xiangnan; Kang, Junnan; Wang, Yifei; He, Yicheng; Yang, Meng; Lu, Ting; Lu, Shihong; Qian, Pengxu; Zhu, Ping; Cheng, Hui; Cheng, Tao.
Affiliation
  • Zheng Z; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Yang S; Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Gou F; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Tang C; Department of Stem Cell and Regenerative Medicine, Chinese Academy of Medical Sciences Center for Stem Cell Medicine, Peking Union Medical College, Tianjin, China.
  • Zhang Z; The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, Key Laboratory of Immune Microenvironment and Disease (Ministry of Education), Department of Cell Biology, Tianjin Medical University, Tianjin, China.
  • Gu Q; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Sun G; Department of Stem Cell and Regenerative Medicine, Chinese Academy of Medical Sciences Center for Stem Cell Medicine, Peking Union Medical College, Tianjin, China.
  • Jiang P; Center for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Liangzhu Laboratory, Zhejiang University Medical Center, Institute of Hematology, Zhejiang University, Zhejiang Engineering Laboratory for S
  • Wang N; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Zhao X; Department of Stem Cell and Regenerative Medicine, Chinese Academy of Medical Sciences Center for Stem Cell Medicine, Peking Union Medical College, Tianjin, China.
  • Kang J; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Wang Y; Department of Stem Cell and Regenerative Medicine, Chinese Academy of Medical Sciences Center for Stem Cell Medicine, Peking Union Medical College, Tianjin, China.
  • He Y; Center for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Liangzhu Laboratory, Zhejiang University Medical Center, Institute of Hematology, Zhejiang University, Zhejiang Engineering Laboratory for S
  • Yang M; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Lu T; Department of Stem Cell and Regenerative Medicine, Chinese Academy of Medical Sciences Center for Stem Cell Medicine, Peking Union Medical College, Tianjin, China.
  • Lu S; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Qian P; Department of Stem Cell and Regenerative Medicine, Chinese Academy of Medical Sciences Center for Stem Cell Medicine, Peking Union Medical College, Tianjin, China.
  • Zhu P; Department of Hematology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Cheng H; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.
  • Cheng T; Department of Stem Cell and Regenerative Medicine, Chinese Academy of Medical Sciences Center for Stem Cell Medicine, Peking Union Medical College, Tianjin, China.
Blood ; 144(7): 742-756, 2024 Aug 15.
Article in En | MEDLINE | ID: mdl-38657191
ABSTRACT
ABSTRACT Hematopoietic differentiation is controlled by intrinsic regulators and the extrinsic hematopoietic niche. Activating transcription factor 4 (ATF4) plays a crucial role in the function of fetal and adult hematopoietic stem cell maintenance. However, the precise function of ATF4 in the bone marrow (BM) niche and the mechanism by which ATF4 regulates adult hematopoiesis remain largely unknown. Here, we used 4 cell-type-specific mouse Cre lines to achieve conditional knockout of Atf4 in Cdh5+ endothelial cells, Prx1+ BM stromal cells, Osx+ osteoprogenitor cells, and Mx1+ hematopoietic cells and uncovered the role of Atf4 in niche cells and hematopoiesis. Intriguingly, depletion of Atf4 in niche cells did not affect hematopoiesis; however, Atf4-deficient hematopoietic cells exhibited erythroid differentiation defects, leading to hypoplastic anemia. Mechanistically, ATF4 mediated direct regulation of Rps19bp1 transcription, which is, in turn, involved in 40 S ribosomal subunit assembly to coordinate ribosome biogenesis and promote erythropoiesis. Finally, we demonstrate that under conditions of 5-fluorouracil-induced stress, Atf4 depletion impedes the recovery of hematopoietic lineages, which requires efficient ribosome biogenesis. Taken together, our findings highlight the indispensable role of the ATF4-RPS19BP1 axis in the regulation of erythropoiesis.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribosomes / Erythropoiesis / Activating Transcription Factor 4 Limits: Animals Language: En Journal: Blood Year: 2024 Document type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ribosomes / Erythropoiesis / Activating Transcription Factor 4 Limits: Animals Language: En Journal: Blood Year: 2024 Document type: Article Affiliation country: China